Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:08 AM
Ignite Modification Date:
2025-12-26 @ 11:08 AM
NCT ID:
NCT02977312
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Newly diagnosed patients with Ph+ CML in CP; or CML patients who started with Cemivil treatment since its registration in Jordan and who confirmed CHR
* Written informed consent
Exclusion Criteria:
* Age \<18 years
* CML in accelerated phase
* CML in blast crisis
* CML with mutation(s) in the BCR-ABL gene
* Contraindications to the administration of the study drug according to the approved Summary of Product Characteristics (SPC)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02977312
Study Brief:
Protocol Section:
NCT02977312